Fusion Pharmaceuticals Inc. Collaboration Agreements
5 Contracts & Agreements
- Amendment No. 3 to Collaboration Agreement, dated August 12, 2021, by and between TRIUMF Innovations Inc. and TRIUMF JV and the Company (Filed With SEC on November 9, 2021)
- Amendment No. 2 to Collaboration Agreement, dated July 27, 2021, by and between TRIUMF Innovations Inc. and TRIUMF JV and the Company (Filed With SEC on November 9, 2021)
- Amendment No. 1 to Collaboration Agreement, dated June 28, 2021, by and between TRIUMF Innovations Inc. and TRIUMF JV and the Company (Filed With SEC on November 9, 2021)
- Collaboration Agreement, dated December 10, 2020, by and between TRIUMF Innovations Inc. and TRIUMF JV and the Company (Filed With SEC on November 9, 2021)
- Strategic Collaboration Agreement by and between Fusion Pharmaceuticals Inc. and AstraZeneca UK Limited, dated October 30, 2020 (Filed With SEC on November 2, 2020)
